Is Mineralys Therapeutics Inc (NASDAQ: MLYS) Back In The Buying Zone?
Currently, there are 49.82M common shares owned by the public and among those 24.58M shares have been available to trade. The company’s stock has a 5-day price change of 67.34% and 19.20% over the past three months. MLYS shares are trading 21.53% year to date (YTD), with the 12-month market performance up to 6.86% higher. […]
